跳至主要内容
临床试验/IRCT2012102811289N1
IRCT2012102811289N1已完成未知

Comparison of the effect of Intravenous immunoglobulin and rhophylac in treatment of immune thrombocytopenic purpura

Arak University of Medical Sciences, Vice Chancellor for Research0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 year 至 15 years(—)
性别
All

入选标准

  • 1.Age upper 1 year and lower 15 years old in patients with acute or chronic ITP
  • 2.Platelets <30000 at the time of treatment
  • 3.Patients entered in the study that parental consent was obtained
  • Exclusion criteria:
  • 1.Splenectomy patients
  • 2.Hemoglobin below 10 g/dL
  • 3.Patients who have been treated with IVIG or rhophylac in the past three weeks
  • 4.Patients with renal insufficiency
  • 5.Total bilirubin above 2 mg per deciliter and higher than normal liver enzymes
  • 6.Patients who have a positive direct Coombs test
  • 7.Patients who are infected with HIV or hepatitis C or B
  • 8.Patients with lupus erythematosus
  • 9.Patients with cardiovascular disease
  • 10.Rh-negative patients

排除标准

  • 未提供

研究者

发起方
Arak University of Medical Sciences, Vice Chancellor for Research

相似试验